Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus magnesium sulfate for bleeding control in lumbar surgery
IRCT20160307026950N59Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in lumbar spinal fusion comparing Magnesium sulfate with Dexmedetomidine (2 arms). Primary endpoints: Systolic blood pressure, Diastolic blood pressure and 2 more. Started Aug 2024; status: completed.
02
Drugs
dexmedetomidinemagnesium sulfate
03
Conditions
lumbar spinal fusion
Beyond the preview
Go deeper on IRCT20160307026950N59.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160307026950N59.